P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro

Pharmaceutical Research

Volumn 21, Issue 7, 2004, Pages 1284-1293

  Kim, Winnie Y ^a   Benet, Leslie Z ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

induction; LS180; MDCK; MDR1; MDR1 MDCK; P glycoprotein; sex steroid hormones; transport

Indexed keywords

ADENOSINE TRIPHOSPHATASE; COMPLEMENTARY DNA; ELACRIDAR; ESTRIOL; ESTROGEN; ESTRONE; ETHINYLESTRADIOL; GESTAGEN; GLYCOPROTEIN P; GLYCOPROTEIN P INHIBITOR; MESSENGER RNA; NORETHISTERONE; SEX HORMONE; VANADIC ACID;

ANIMAL CELL; ARTICLE; BACULOVIRUS; CANCER CELL CULTURE; CARCINOMA CELL; CATALYSIS; CELL MEMBRANE; CELL STRAIN; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG TRANSPORT; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GENETIC TRANSFECTION; HORMONE TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; INSECT CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MEASUREMENT; METABOLITE; MULTIDRUG RESISTANCE 1 GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; STIMULATION; TIME; VIRUS INFECTION; VIRUS RECOMBINANT; WESTERN BLOTTING;

ACRIDINES; ANIMALS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CELL LINE; CHROMATOGRAPHY, LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL CONGENERS; FEMALE; HUMANS; MASS SPECTROMETRY; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAHYDROISOQUINOLINES; TIME FACTORS;

EID: 3242695290     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000033017.52484.81     Document Type: Article

References (35)

1. S. V. Ambudkar, S. Dey, C. A. Hrycyna, M. Ramachandra, I. Pastan, and M. M. Gottesman. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39:361-398 (1999).
2. M. M. Gottesman, I. Pastan, and S. V. Ambudkar. P-glycoprotein and multidrug resistance. Curr. Opin. Genet. Dev. 6:610-617 (1996).
3. C. L. Cummins, L. M. Mangravite, and L. Z. Benet. Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1. and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Pharm. Res. 18:1102-1109 (2001).
4. A. Nakayama, O. Eguchi, M. Hatakeyama, H. Saitoh, and M. Takada. Different absorption behaviors among steroid hormones due to possible interaction with P-glycoprotein in the rat small intestine. Biol. Pharm. Bull. 22:535-538 (1999).
5. I. Sugawara, M. Nakahama, H. Hamada, T. Tsuruo, and S. Mori. Apparent stronger expression in the human adrenal cortex than in the human adrenal medulla of Mr 170,000-180,000 P-glycoprotein. Cancer Res. 48:4611-4614 (1988).
6. I. Sugawara. Expression and functions of P-glycoprotein (mdr1 gene product) in normal and malignant tissues. Acta Pathol. Jpn. 40:545-553 (1990).
7. N. Kioka, J. Tsubota, Y. Kakehi, T. Komano, M. M. Gottesman, I. Pastan, and K. Ueda. P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem. Biophys. Res. Commun. 162:224-231 (1989).
8. M. Naito, K. Yusa, and T. Tsuruo. Steroid hormones inhibit binding of Vinca alkaloid to multidrug resistance related P-glycoprotein. Biochem. Biophys. Res. Commun. 158:1066-1071 (1989).
9. C. K. van Kalken, H. J. Broxterman, H. M. Pinedo, N. Feller, H. Dekker, J. Lankelma, and G. Giaccone. Cortisol is transported by the multidrug resistance gene product P-glycoprotein. Br. J. Cancer 67:284-289 (1993).
10. K. Ueda, N. Okamura, M. Hirai, Y. Tanigawara, T. Saeki, N. Kioka, T. Komano, and R. Hori. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J. Biol. Chem. 267:24248-24252 (1992).
11. M. Uhr, F. Holsboer, and M. B. Muller. Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. J. Neuroendocrinol. 14:753-759 (2002).
12. M. Ichikawa-Haraguchi, T. Sumizawa, A. Yoshimura, T. Furukawa, S. Hiramoto, M. Sugita, and S. Akiyama. Progesterone and its metabolites: the potent inhibitors of the transporting activity of P-glycoprotein in the adrenal gland. Biochim. Biophys. Acta 1158:201-208 (1993).
13. K. M. Barnes, B. Dickstein, G. B. Cutler Jr., T. Fojo, and S. E. Bates. Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells. Biochemistry 35:4820-4827 (1996).
14. K. O. Hamilton, M. A. Yazdanian, and K. L. Audus. Modulation of P-glycoprotein activity in Calu-3 cells using steroids and beta-ligands. Int. J. Pharm. 228:171-179 (2001).
15. H. Fujise, T. Annoura, S. Sasawatari, T. Ikeda, and K. Ueda. Transepithelial transport and cellular accumulation of steroid hormones and polychlorobiphenyl in porcine kidney cells expressed with human P-glycoprotein. Chemosphere 46:1505-1511 (2002).
16. J. T. Bung, Y. F. Yang, H. S. Liu, C. T. Ye, and C. F. Chao. The induction of multidrug resistance in human cervical carcinoma cell lines by estrogenic hormones. Proc. Natl. Sci. Counc. Repub. China B 18:64-70 (1994).
17. L. Zampieri, P. Bianchi, P. Ruff, and P. Arbuthnot. Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cells. Anticancer Res. 22:2253-2259 (2002).
18. S. Altuvia, W. D. Stein, S. Goldenberg, S. E. Kane, I. Pastan, and M. M. Gottesman. Targeted disruption of the mouse mdr1b gene reveals that steroid hormones enhance mdr gene expression. J. Biol. Chem. 268:27127-27132 (1993).
19. J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, and A. G. Gilman, (eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th Ed., McGraw-Hill Health Professions Division, New York, 1996.
20. B. Hanstein, H. Liu, M. C. Yancisin, and M. Brown. Functional analysis of a novel estrogen receptor-beta isoform. Mol. Endocrinol. 13:129-137 (1999).
21. C. A. Axiotis, R. Guarch, M. J. Merino, N. Laporte, and R. D. Neumann. P-glycoprotein expression is increased in human secretory and gestational endometrium. Lab. Invest. 65:577-581 (1991).
22. M. Horio, K. V. Chin, S. J. Currier, S. Goldenberg, C. Williams, I. Pastan, M. M. Gottesman, and J. Handler. Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia. J. Biol. Chem. 264:14880-14884 (1989).
23. B. Sarkadi, E. M. Price, R. C. Boucher, U. A. Germann, and G. A. Scarborough. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J. Biol. Chem. 267:4854-4858 (1992).
24. B. Greiner, M. Eichelbaum, P. Fritz, H. P. Kreichgauer, O. von Richter, J. Zundler, and H. K. Kroemer. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. J. Clin. Invest. 104:147-153 (1999).
25. A. Geick, M. Eichelbaum, and O. Burk. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. J. Biol. Chem. 276:14581-14587 (2001).
26. R. J. Arceci, J. M. Croop, S. B. Horwitz, and D. Housman. The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc. Natl. Acad. Sci. U.S.A. 85:4350-4354 (1988).
27. C. P. Yang, S. G. DePinho, L. M. Greenberger, R. J. Arceci, and S. B. Horwitz. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. J. Biol. Chem. 264:782-788 (1989).
28. R. J. Arceci, F. Baas, R. Raponi, S. B. Horwitz, D. Housman, and J. M. Croop. Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus. Mol. Reprod. Dev. 25:101-109 (1990).
29. J. V. Wright, B. Schliesman, and L. Robinson. Comparative measurements of serum estriol, estradiol, and estrone in non-pregnant, premenopausal women; a preliminary investigation. Altern. Med. Rev. 4:266-270 (1999).
30. R. A. Boyd, E. A. Zegarac, and M. A. Eldon. The effect of food on the bioavailability of norethindrone and ethinyl estradiol from norethindrone acetate/ethinyl estradiol tablets intended for continuous hormone replacement therapy. J. Clin. Pharmacol. 43:52-58 (2003).
31. J. Endrikat, H. Blode, C. Gerlinger, P. Rosenbaum, and W. Kuhnz. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel. Eur. J. Contracept. Reprod. Health Care 7:79-90 (2002).
32. R. L. Piekarz, D. Cohen, and S. B. Horwitz. Progesterone regulates the murine multidrug resistance mdr1b gene. J. Biol. Chem. 268:7613-7616 (1993).
33. S. M. Tsunoda, R. Z. Harris, P. J. Mroczkowski, and L. Z. Benet. Preliminary evaluation of progestins as inducers of cytochrome P450 3A4 activity in postmenopausal women. J. Clin. Pharmacol. 38:1137-1143 (1998).
34. S. Palovaara, K. T. Kivisto, P. Tapanainen, P. Manninen, P. J. Neuvonen, and K. Laine. Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1'-hydroxylation. Br. J. Clin. Pharmacol. 50:333-337 (2000).
35. M. L. Orme and D. J. Back. Factors affecting the enterohepatic circulation of oral contraceptive steroids. Am. J. Obstet. Gynecol. 163:2146-2152 (1990).